Johns Hopkins ABX Guide
Ceftaroline
INDICATIONS
FDA
FDA
- Acute bacterial skin and skin structure infections (ABSSSIs)
- Due to susceptible organisms: S. aureus(including MRSA), S. pyogenes, S. agalactiae, E.coli, K. pneumoniae, K. oxytoca.
- Community acquired pneumonia (including cases caused by PCN-resistant S. pneumoniae)
- Due to susceptible organisms: S. pneumoniae (including cases with bacteremia), MSSA, H. influenzae, K. pneumoniae, E. coli
- Due to susceptible organisms: S. pneumoniae (including cases with bacteremia), MSSA, H. influenzae, K. pneumoniae, E. coli
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- MRSA infections not listed above
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 4, 2017
Citation
Pham, Paul A. "Ceftaroline." Johns Hopkins ABX Guide, The Johns Hopkins University, 2017. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540100/5.2/Ceftaroline.
Pham PA. Ceftaroline. Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540100/5.2/Ceftaroline. Accessed December 26, 2024.
Pham, P. A. (2017). Ceftaroline. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540100/5.2/Ceftaroline
Pham PA. Ceftaroline [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. [cited 2024 December 26]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540100/5.2/Ceftaroline.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ceftaroline
ID - 540100
A1 - Pham,Paul,Pharm.D. BCPS
Y1 - 2017/10/04/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540100/5.2/Ceftaroline
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
